The effects of NOD2/CARD15 mutations on the function of the intestinal barrier

Journal of Crohn's and Colitis

Volumn 1, Issue 2, 2007, Pages 53-60

  Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Defensins; ; Epithelial barrier; ; GvHD; Intestinal epethelial cellls; ; Intestinal macrophages (IMACs); ; Intestinal permeability; ; NOD2 CARD15; ; Pattern recognition receptors (PRRs);

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; DEFENSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MURAMYL DIPEPTIDE; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TRANSCRIPTION FACTOR;

BACTERIAL CELL WALL; BACTERIAL TRANSLOCATION; CROHN DISEASE; CYTOKINE RELEASE; EPITHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GRAFT VERSUS HOST REACTION; HUMAN; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MACROPHAGE; MUCOSA INFLAMMATION; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

EID: 37249066691     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2007.08.008     Document Type: Review

References (79)

1. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
2. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
3. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
4. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
5. Hanauer S.B. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12 Suppl 1 (2006) S3-S9
6. MacDonald T.T., Di Sabatino A., and Gordon J.N. Immunopathogenesis of Crohn's disease. JPEN J Parenter Enteral Nutr 29 (2005) S118-S124 [discussion S124-5, S184-8]
7. Rogler G. Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 20 (2004) 311-317
8. Marks D.J., Harbord M.W., MacAllister R., et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 367 (2006) 668-678
9. Vind I., Vieira A., Hougs L., et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion 72 (2005) 156-163
10. Buning C., Genschel J., Buhner S., et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther 19 (2004) 1073-1078
11. Cuthbert A.P., Fisher S.A., Mirza M.M., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122 (2002) 867-874
12. Vermeire S., Wild G., Kocher K., et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71 (2002) 74-83
13. Ferraris A., Torres B., Knafelz D., et al. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. Inflamm Bowel Dis 12 (2006) 355-361
14. Seiderer J., Schnitzler F., Brand S., et al. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol 41 (2006) 1421-1432
15. Abreu M.T., Taylor K.D., Lin Y.C., et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 123 (2002) 679-688
16. Alvarez-Lobos M., Arostegui J.I., Sans M., et al. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 242 (2005) 693-700
17. Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol 20 (2004) 82-88
18. Gutierrez O., Pipaon C., Inohara N., et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277 (2002) 41701-41705
19. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., and Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276 (2001) 4812-4818
20. Lala S., Ogura Y., Osborne C., et al. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125 (2003) 47-57
21. Berrebi D., Maudinas R., Hugot J.P., et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52 (2003) 840-846
22. Ogura Y., Lala S., Xin W., et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52 (2003) 1591-1597
23. Uehara A., Fujimoto Y., Fukase K., and Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44 (2007) 3100-3111
24. Rosenstiel P., Sina C., End C., et al. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol 178 (2007) 8203-8211
25. Swerdlow M.P., Kennedy D.R., Kennedy J.S., et al. Expression and function of TLR2, TLR4, and Nod2 in primary canine colonic epithelial cells. Vet Immunol Immunopathol 114 (2006) 313-319
26. Rosenstiel P., Fantini M., Brautigam K., et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124 (2003) 1001-1009
27. Hisamatsu T., Suzuki M., Reinecker H.C., Nadeau W.J., McCormick B.A., and Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124 (2003) 993-1000
28. Hausmann M., Kiessling S., Mestermann S., et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122 (2002) 1987-2000
29. Rogler G., Hausmann M., Vogl D., et al. Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 112 (1998) 205-215
30. Chamaillard M., Girardin S.E., Viala J., and Philpott D.J. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5 (2003) 581-592
31. Martinon F., and Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26 (2005) 447-454
32. Strauch U.G., Obermeier F., Grunwald N., et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 54 (2005) 1546-1552
33. Obermeier F., Strauch U.G., Dunger N., et al. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4 +CD62L + T cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut 54 (2005) 1428-1436
34. Obermeier F., Dunger N., Strauch U.G., et al. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol 134 (2003) 217-224
35. Hausmann M., Spottl T., Andus T., et al. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages. Clin Exp Immunol 125 (2001) 48-55
36. Kobayashi K.S., Chamaillard M., Ogura Y., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
37. Inohara N., Ogura Y., Fontalba A., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278 (2003) 5509-5512
38. Girardin S.E., Boneca I.G., Viala J., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 (2003) 8869-8872
39. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3 (2003) 371-382
40. Inohara N., del Peso L., Koseki T., Chen S., and Nunez G. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem 273 (1998) 12296-12300
41. Inohara N., Koseki T., Lin J., et al. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 275 (2000) 27823-27831
42. Barnich N., Aguirre J.E., Reinecker H.C., Xavier R., and Podolsky D.K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol 170 (2005) 21-26
43. Pan Q., Kravchenko V., Katz A., et al. NF-kappa B-inducing kinase regulates selected gene expression in the Nod2 signaling pathway. Infect Immun 74 (2006) 2121-2127
44. Abreu M.T. Nod2 in normal and abnormal intestinal immune function. Gastroenterology 129 (2005) 1302-1304
45. Folwaczny C., Glas J., and Torok H.P. Crohn's disease: an immunodeficiency?. Eur J Gastroenterol Hepatol 15 (2003) 621-626
46. Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 22 (2006) 95-101
47. Chen L.W., Chen P.H., Chang W.J., Wang J.S., Karin M., and Hsu C.M. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation. Crit Care Med 35 (2007) 1332-1340
48. Zaph C., Troy A.E., Taylor B.C., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446 (2007) 552-556
49. Nenci A., Becker C., Wullaert A., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561
50. Balzan S., de Almeida Quadros C., de Cleva R., Zilberstein B., and Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 22 (2007) 464-471
51. McCole D.F., and Barrett K.E. Epithelial transport and gut barrier function in colitis. Curr Opin Gastroenterol 19 (2003) 578-582
52. Baumgart D.C., and Dignass A.U. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 5 (2002) 685-694
53. Zeissig S., Burgel N., Gunzel D., et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56 (2007) 61-72
54. Shen L., and Turner J.R. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol 290 (2006) G577-G582
55. Bruewer M., Samarin S., and Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 1072 (2006) 242-252
56. Abreu M.T., Fukata M., and Arditi M. TLR signaling in the gut in health and disease. J Immunol 174 (2005) 4453-4460
57. Ganz T. Microbiology: Gut defence. Nature 422 (2003) 478-479
58. Wehkamp J., Schmid M., Fellermann K., and Stange E.F. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 77 (2005) 460-465
59. Bick R.J., Poindexter B.J., Bhat S., Gulati S., Buja M., and Milner S.M. Effects of cytokines and heat shock on defensin levels of cultured keratinocytes. Burns 30 (2004) 329-333
60. Wehkamp K., Schwichtenberg L., Schroder J.M., and Harder J. Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 126 (2006) 121-127
61. Wehkamp J., Fellermann K., Herrlinger K.R., Bevins C.L., and Stange EF. Mechanisms of disease: defensins in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 406-415
62. Wehkamp J., and Stange E.F. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 1072 (2006) 321-331
63. Voss E., Wehkamp J., Wehkamp K., Stange E.F., Schroder J.M., and Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281 (2006) 2005-2011
64. Wehkamp J., Harder J., Weichenthal M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53 (2004) 1658-1664
65. Wehkamp J., Harder J., Weichenthal M., et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 9 (2003) 215-223
66. Hermiston M.L., and Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270 (1995) 1203-1207
67. Barnich N., Hisamatsu T., Aguirre J.E., Xavier R., Reinecker H.C., and Podolsky D.K. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem 280 (2005) 19021-19026
68. Hollander D. Permeability in Crohn's disease: altered barrier functions in healthy relatives?. Gastroenterology 104 (1993) 1848-1851
69. Issenman R.M., Jenkins R.T., and Radoja C. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease. Clin Invest Med 16 (1993) 187-196
70. Soderholm J.D., Peterson K.H., Olaison G., et al. Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease?. Gastroenterology 117 (1999) 65-72
71. Schurmann G., Bruwer M., Klotz A., Schmid K.W., Senninger N., and Zimmer K.P. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis 14 (1999) 41-46
72. Peeters M., Geypens B., Claus D., et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 113 (1997) 802-807
73. D'Inca R., Annese V., di Leo V., et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment Pharmacol Ther 23 (2006) 1455-1461
74. Buhner S., Buning C., Genschel J., et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?. Gut 55 (2006) 342-347
75. Finch P.W., and Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 91 (2004) 69-136
76. Gerbitz A., Schultz M., Wilke A., et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103 (2004) 4365-4367
77. Holler E., Rogler G., Brenmoehl J., et al. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107 (2006) 4189-4193
78. Rogler G., and Holler E. Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?. Nat Clin Pract Gastroenterol Hepatol 1 (2004) 62-63
79. Holler E., Rogler G., Herfarth H., et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104 (2004) 889-894